{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T23:30:56Z","timestamp":1782516656930,"version":"3.54.5"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T00:00:00Z","timestamp":1743984000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T00:00:00Z","timestamp":1743984000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urogynecol J"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1007\/s00192-025-06121-1","type":"journal-article","created":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T04:23:30Z","timestamp":1744086210000},"page":"1641-1647","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Impact of Type and Duration of Oral Antibiotic Prophylaxis on Urinary-Tract Infection Rate After Botox"],"prefix":"10.1007","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8485-7057","authenticated-orcid":false,"given":"Bayley","family":"Clarke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella","family":"Yacovone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JooHee","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Marantidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marguerite","family":"Furlong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis A.","family":"Dieter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,7]]},"reference":[{"issue":"13","key":"6121_CR1","doi-asserted-by":"publisher","first-page":"136674","DOI":"10.1001\/jama.2016.14617","volume":"316","author":"CL Amundsen","year":"2016","unstructured":"Amundsen CL, Richter HE, Menefee SA, Komesu  YM, Arya  LA, Gregory WT, et al. OnabotulinumtoxinA vs sacral neuromodulation on refractory urgency urinary incontinence in women: a randomized clinical trial. JAMA. 2016;316(13):136674. https:\/\/doi.org\/10.1001\/jama.2016.14617.","journal-title":"JAMA"},{"issue":"6","key":"6121_CR2","doi-asserted-by":"publisher","first-page":"2608","DOI":"10.1016\/j.juro.2009.01.117","volume":"181","author":"MK Flynn","year":"2009","unstructured":"Flynn MK, Amundsen CL, Perevich M, Liu F, Webster GD. Outcome of a randomized, double-blind, placebo controlled trial of botulinum A toxin for refractory overactive bladder. J Urol. 2009;181(6):2608\u201315. https:\/\/doi.org\/10.1016\/j.juro.2009.01.117.","journal-title":"J Urol"},{"issue":"6","key":"6121_CR3","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1016\/j.juro.2007.01.130","volume":"177","author":"A Sahai","year":"2007","unstructured":"Sahai A, Khan MS, Dasgupta P. Efficacy of botulinum toxin-A for treating idiopathic detrusor overactivity: results from a single center, randomized, double-blind, placebo controlled trial. J Urol. 2007;177(6):2231\u20136. https:\/\/doi.org\/10.1016\/j.juro.2007.01.130.","journal-title":"J Urol"},{"issue":"1","key":"6121_CR4","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1097\/JU.0000000000003985","volume":"212","author":"AP Cameron","year":"2024","unstructured":"Cameron AP, Chung DE, Dielubanza EJ, Enemchukwu E, Ginsberg DA, Helfand BT, et al. The AUA\/SUFU guideline on the diagnosis and treatment of idiopathic overactive bladder. J Urol. 2024;212(1):11\u201320. https:\/\/doi.org\/10.1097\/JU.0000000000003985.","journal-title":"J Urol"},{"key":"6121_CR5","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1016\/j.juro.2015.01.087","volume":"193","author":"EA Gormley","year":"2015","unstructured":"Gormley EA, Lightner DJ, Faraday M, Vasavada SP; American Urological Association; Society of Urodynamics, Female Pelvic Medicine. Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA\/SUFU guideline amendment. J Urol. 2015;193:1572\u201380. https:\/\/doi.org\/10.1016\/j.juro.2015.01.087.","journal-title":"J Urol."},{"key":"6121_CR6","unstructured":"Botox label\u2014accessdata.fda.gov. Medication Guide Botox.\u00a0https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2011\/103000s5232lbl.pdf. Highlights of prescribing information. These highlights do not include all the information needed to use BOTOX\u00ae safely and effectively. See full prescribing information for BOTOX. BOTOX (onabotulinumtoxinA) for injection, for intramuscular, intradetrusor, or intradermal use Initial U.S. Approval: 1989.(n.d.).\u00a0Accessed 10 Nov 2024."},{"issue":"2","key":"6121_CR7","doi-asserted-by":"publisher","first-page":"3516","DOI":"10.1097\/JU.0000000000000509","volume":"203","author":"DJ Lightner","year":"2020","unstructured":"Lightner DJ, Wymer K, Sanchez J, Kavoussi L. Best practice statement on urologic procedures and antimicrobial prophylaxis. J Urol. 2020;203(2):3516. https:\/\/doi.org\/10.1097\/JU.0000000000000509.","journal-title":"J Urol"},{"issue":"5","key":"6121_CR8","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1007\/s00192-018-3721-4","volume":"30","author":"J Houman","year":"2019","unstructured":"Houman J, Moradzadeh A, Patel DN, Asanad K, Anger JT, Eilber KS. What is the ideal antibiotic prophylaxis for intravesically administered Botox injection? A comparison of two different regimens. Int Urogynecol J. 2019;30(5):701\u20134. https:\/\/doi.org\/10.1007\/s00192-018-3721-4.","journal-title":"Int Urogynecol J"},{"issue":"2020","key":"6121_CR9","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1007\/s00192-020-04230-7","volume":"31","author":"JA Bickhaus","year":"2020","unstructured":"Bickhaus JA, Vaughan M, Truong T, Li  YJ, Siddiqui NY. A comparison of antibiotic prophylaxis regimens to decrease the risk of post-procedure urinary tract infection after onabotulinum toxin a injection. Int Urogynecol J. 2020;31(2020):1907\u201312.","journal-title":"Int Urogynecol J"},{"key":"6121_CR10","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1007\/s00192-021-04691-4","volume":"33","author":"SE Eckhardt","year":"2022","unstructured":"Eckhardt SE, Takashima Y, Handler SJ, Tenggardjaja  C, Yazdany  T. Antibiotic regimen and route of administration do not alter rates of urinary tract infection after intravesical botulinum toxin injection for overactive bladder. Int Urogynecol J. 2022;33:703\u20139. https:\/\/doi.org\/10.1007\/s00192-021-04691-4.","journal-title":"Int Urogynecol J"},{"key":"6121_CR11","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.urology.2022.05.003","volume":"166","author":"S Martin","year":"2022","unstructured":"Martin S, Zillioux J, Goldman HB, Slopnick E. Impact of duration of antibiotic prophylaxis on incidence of UTI after OnabotulinumtoxinA injection. Urology. 2022;166:140\u20135. https:\/\/doi.org\/10.1016\/j.urology.2022.05.003.","journal-title":"Urology"},{"issue":"1","key":"6121_CR12","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s00192-023-05665-4","volume":"35","author":"FW Getaneh","year":"2024","unstructured":"Getaneh FW, Simhal R, Sholklapper T, Melvin E, Dorris CS, Chou J, Richter LA, Dieter A. Antibiotic prophylaxis for onabotulinum toxin A injections: systematic review and meta-analysis. Int Urogynecol J. 2024;35(1):19\u201329. https:\/\/doi.org\/10.1007\/s00192-023-05665-4.","journal-title":"Int Urogynecol J"},{"issue":"3","key":"6121_CR13","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1097\/SPV.0000000000001466","volume":"30","author":"CW Heuer","year":"2024","unstructured":"Heuer CW, Gisseman J, Vaccaro CM, Olsen CH, Galgano AC, Dengler KL. Antibiotics for UTI prevention after intradetrusor OnabotulinumtoxinA injections. Urogynecology. 2024;30(3):272\u20139. https:\/\/doi.org\/10.1097\/SPV.0000000000001466.","journal-title":"Urogynecology"},{"issue":"8","key":"6121_CR14","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1016\/j.ajic.2021.01.009","volume":"49","author":"BG Mitchell","year":"2021","unstructured":"Mitchell BG, Prael G, Curryer C, Russo PL, Fasugba O, Lowthian J, Cheng AC, Archibold J, Robertson M, Kiernan M. The frequency of urinary tract infections and the value of antiseptics in community-dwelling people who undertake intermittent urinary catheterization: a systematic review. Am J Infect Control. 2021;49(8):1058\u201365. https:\/\/doi.org\/10.1016\/j.ajic.2021.01.009.","journal-title":"Am J Infect Control"},{"issue":"8","key":"6121_CR15","doi-asserted-by":"publisher","first-page":"343","DOI":"10.3390\/toxins16080343","volume":"16","author":"PH Yu","year":"2024","unstructured":"Yu PH, Wang CC. Adverse effects of intravesical onabotulinumtoxinA injection in patients with idiopathic overactive bladder or neurogenic detrusor overactivity: a systematic review and meta-analysis of randomized controlled studies. Toxins (Basel). 2024;16(8):343. https:\/\/doi.org\/10.3390\/toxins16080343.","journal-title":"Toxins (Basel)"},{"key":"6121_CR16","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.urology.2016.10.026","volume":"100","author":"H L\u00f3pez Ramos","year":"2017","unstructured":"L\u00f3pez Ramos H, Torres Castellanos L, Ponce Esparza I, Jaramillo A, Rodr\u00edguez A, Moreno Bencardino C. management of overactive bladder with OnabotulinumtoxinA: systematic review and meta-analysis. Urology. 2017;100:53\u20138. https:\/\/doi.org\/10.1016\/j.urology.2016.10.026.","journal-title":"Urology"},{"key":"6121_CR17","unstructured":"The Joint Commission. Antimicrobial Stewardship. (n.d.); www.jointcomission.org. Accessed 10 Nov 2024. Available at:\u00a0http:\/\/www.jointcomission.org\/resources\/patient-safety-topics\/infection-prevention-and-control\/antibioctic-stewardship."},{"issue":"1","key":"6121_CR18","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1186\/s12879-022-07167-y","volume":"22","author":"MW Dunne","year":"2022","unstructured":"Dunne MW, Aronin SI, Yu KC, Watts JA, Gupta V. A multicenter analysis of trends in resistance in urinary Enterobacterales isolates from ambulatory patients in the United States: 2011\u20132020. BMC Infect Dis. 2022;22(1):194. https:\/\/doi.org\/10.1186\/s12879-022-07167-y.","journal-title":"BMC Infect Dis"},{"key":"6121_CR19","unstructured":"MedStar Washington Hospital Center Antimicrobial Susceptibility Profile (1 January 2022 to 31 December 2022). MedStar Washington Hospital Center 2022."},{"issue":"1","key":"6121_CR20","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1086\/313596","volume":"30","author":"R Raz","year":"2000","unstructured":"Raz R, Gennesin Y, Wasser J, Stoler Z, Rosenfeld S, Rottensterich E, Stamm WE. Recurrent urinary tract infections in postmenopausal women. Clin Infect Dis. 2000;30(1):152\u20136. https:\/\/doi.org\/10.1086\/313596.","journal-title":"Clin Infect Dis"},{"issue":"5","key":"6121_CR21","doi-asserted-by":"publisher","first-page":"e103","DOI":"10.1093\/cid\/ciq257","volume":"52","author":"K Gupta","year":"2011","unstructured":"Gupta K, Hooton TM, Naber KG, Wullt B, Colgan R, Miller LG, Moran GJ, Nicolle LE, Raz R, Schaeffer AJ, Soper DE. Infectious Diseases Society of America; European Society for Microbiology and Infectious Diseases. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis. 2011;52(5):e103\u201320. https:\/\/doi.org\/10.1093\/cid\/ciq257.","journal-title":"Clin Infect Dis"}],"container-title":["International Urogynecology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00192-025-06121-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00192-025-06121-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00192-025-06121-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T13:35:52Z","timestamp":1758807352000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00192-025-06121-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,7]]},"references-count":21,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["6121"],"URL":"https:\/\/doi.org\/10.1007\/s00192-025-06121-1","relation":{},"ISSN":["0937-3462","1433-3023"],"issn-type":[{"value":"0937-3462","type":"print"},{"value":"1433-3023","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,7]]},"assertion":[{"value":"21 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Approved by the MedStar Health Research Institute IRB STUDY00006837.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Institutional Review Board"}},{"value":"None.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest"}}]}}